Cboe UK GBp

Dr. Martens plc (DOCSL.XC)

75.15
-1.88
(-2.43%)
As of 2:17:46 PM GMT+1. Market Open.
Loading Chart for DOCSL.XC
  • Previous Close 77.03
  • Open 75.05
  • Bid 75.05 x --
  • Ask 75.15 x --
  • Day's Range 73.25 - 76.10
  • 52 Week Range 45.00 - 83.30
  • Volume 252,060
  • Avg. Volume 375,897
  • Market Cap (intraday) 745.756M
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 7,515.00
  • EPS (TTM) 0.01
  • Earnings Date Jun 5, 2025
  • Forward Dividend & Yield 0.03 (3.31%)
  • Ex-Dividend Date Aug 28, 2025
  • 1y Target Est --

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.

www.drmartensplc.com

2,348

Full Time Employees

March 30

Fiscal Year Ends

Recent News: DOCSL.XC

View More

Performance Overview: DOCSL.XC

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

DOCSL.XC
3.49%
FTSE 100 (^FTSE)
8.48%

1-Year Return

DOCSL.XC
9.60%
FTSE 100 (^FTSE)
8.60%

3-Year Return

DOCSL.XC
68.97%
FTSE 100 (^FTSE)
23.04%

5-Year Return

DOCSL.XC
72.29%
FTSE 100 (^FTSE)
45.22%

Compare To: DOCSL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCSL.XC

View More

Valuation Measures

Annual
As of 6/12/2025
  • Market Cap

    737.84M

  • Enterprise Value

    986.04M

  • Trailing P/E

    154.05

  • Forward P/E

    17.99

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.95

  • Price/Book (mrq)

    2.03

  • Enterprise Value/Revenue

    1.25

  • Enterprise Value/EBITDA

    8.92

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.57%

  • Return on Assets (ttm)

    4.12%

  • Return on Equity (ttm)

    1.23%

  • Revenue (ttm)

    787.6M

  • Net Income Avi to Common (ttm)

    4.5M

  • Diluted EPS (ttm)

    0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    155.9M

  • Total Debt/Equity (mrq)

    110.29%

  • Levered Free Cash Flow (ttm)

    164.56M

Research Analysis: DOCSL.XC

View More

Company Insights: DOCSL.XC

Research Reports: DOCSL.XC

View More

People Also Watch